StaceyMSteinMD

PubMed

• NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
  Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha, May Cho, Anthony Shields, Shubham Pant, Laura Goff, Kristen Spencer, Edward Kim, Stacey Stein, ...> ;British Journal of Cancer. 2024 Feb 1
• Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer.
  Gabrielle W Peters, Wesley Talcott, Nicholas V Peters, Andrew Dhanasopan, Jill Lacy, Michael Cecchini, Jeremy Kortmansky, Stacey Stein, Stephen Lattanzi, Daniel Boffa,...> ;Journal of Gastrointestinal Oncology. 2023 Jun 30
• Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
  Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kort...> ;Cancer Research Communications. 2023 Jun 1
• 1 citations
  Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals.
  Ginny Jacobs, Deborah A Boyle, Hashem B El-Serag, Robert J Lewandowski, Stacey M Stein, Patrice Lazure, Pam McFadden> ;Cancer Medicine. 2023 Feb 1
• 2 citations
  PD-1 targeted immunotherapy for advanced hepatocellular carcinoma: current utilization and outcomes in the USA.
  Johannes Uhlig, Stacey Stein, Hyun S Kim> ;Future Oncology. 2022 May 1
• Yale Precision Medicine Tumor Board: reawakening the guardian of the genome.
  Michael J Grant, Karin E Finberg, Zenta Walther, Stacey M Stein, Jill Lacy, Joseph P Eder, Sarah B Goldberg> ;The Lancet. Oncology. 2022 Mar 1
• 19 citations
  Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
  Samuel J. Klempner, Johanna C. Bendell, Victoria M. Villaflor, Laura LaNiel Tenner, Stacey Stein, James B. Rottman, Girish S. Naik, Cynthia A. Sirard, Michael H. Kagey...> ;Molecular Cancer Therapeutics. 2021 Sep 4
• 6 citations
  Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer.
  Stacey Stein, Jeremy Snider, Siraj M. Ali, Rebecca A. Miksad, Brian M. Alexander, Emily Castellanos, Alexa B. Schrock, Russell Madison, Akshay Swaminathan, Jeffrey M. ...> ;Future Oncology. 2021 Aug 31
• 7 citations
  Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNO...
  E. Van Cutsem, A. Valderrama, Y-J. Bang, Charles S. Fuchs, K. Shitara, Yelena Y. Janjigian, S. Qin, T.G. Larson, Veena Shankaran, Stacey Stein, Josephine M. Norquist, ...> ;ESMO Open. 2021 Aug 1
• The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
  Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Jeffrey Pollak, Tamar H. Taddei, Stacey Stein, Joseph K. Lim, Hyun Soo Kim> ;Cancer Medicine. 2021 Jul 28
• 406 citations
  Hepatobiliary cancers, Version 2.2021
  Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert A. Anders, Chandrakanth Are, Melinda Bachini, Mitesh J. Borad, Daniel B. Brown, Adam M. ...> ;Journal of the National Comprehensive Cancer Network. 2021 May 1
• 5 citations
  Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national c...
  Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol ...> ;Clinical and Translational Radiation Oncology. 2021 Mar 1
• 7 citations
  Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation.
  Cathy Eng, Emerson Y. Chen, Jane E. Rogers, Mark A. Lewis, Jonathan R. Strosberg, Ramya Thota, Smitha S. Krishnamurthi, Paul E. Oberstein, Rang Govindarajan, Gary L. B...> ;JCO Oncology Practice. 2021 Feb 3
• 16 citations
  Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
  Johannes Uhlig, Michael Cecchini, Amar H. Sheth, Stacey Stein, Jill Lacy, Hyun Soo Kim> ;Journal of the National Comprehensive Cancer Network. 2021 Feb 2
• 4 citations
  Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer.
  Kishan Patel, Stacey Stein, Jill Lacy, Mark H. O'Hara, Scott F. Huntington> ;JAMA Network Open. 2021 Jan 4
• Clinical outcomes of first line FOLFIRINOX vs . gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System
  Timil Patel, Joseph A. Miccio, Michael Cecchini, Thejal Srikumar, Stacey Stein, Jeremy Kortmanksy, Kimberly L. Johung, Jill Lacy> ;Journal of Gastrointestinal Oncology. 2021 Jan 1
• 5 citations
  A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
  Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar, Nataliya Volodymyrivna Uboha, Navid Hafez, Jill Lacy, Neal A. Fischbach, Kert D. Sabbath,...> ;Cancer. 2020 Dec 22
• 6 citations
  Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI
  Luzie A. Doemel, Julius Chapiro, Fabian Laage Gaupp, Lynn Jeanette Savic, Ahmet S Kucukkaya, Alexandra Petukhova, Tal Zeevi, MingDe Lin, Todd Schlachter, Ariel Jaffe, ...> ;European Radiology. 2021 May 1
• 33 citations
  Phase I and biomarker study of the wnt pathway modulator dkn-01 in combination with gemcitabine/ cisplatin in advanced biliary tract cancer
  Lipika Goyal, Cynthia A. Sirard, Michael Schrag, Michael H. Kagey, Jennifer R. Eads, Stacey Stein, Anthony B. El-Khoueiry, Gulam Abbas Manji, Thomas A. Abrams, Alok A....> ;Clinical Cancer Research. 2020 Dec 1
• 2 citations
  A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline ...
  Michael Cecchini, Joseph A. Miccio, Jay Pahade, Jill Lacy, Ronald R. Salem, Skyler B. Johnson, Adriana Blakaj, Stacey Stein, Jeremy S. Kortmansky, Kimberly L. Johung> ;Pancreas. 2020 Aug 1
• 5 citations
  Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma.
  William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun Soo Kim> ;Journal of Vascular and Interventional Radiology. 2020 May 4
• 20 citations
  Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer
  Richard D. Kim, Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii-Saab, Stacey M. Stein, Vaibhav Sahai, George P. Keogh, Edward J. Kim, Ari David Baron, Abby B....> ;European Journal of Cancer. 2020 May 1
• 22 citations
  Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma.
  William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun Soo Kim> ;Scientific Reports. 2019 Nov 19
• 9 citations
  The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.
  Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Tamar H. Taddei, Stacey Stein, Joseph K. Lim, Hyun Soo Kim> ;Cancer Medicine. 2019 Aug 22
• 24 citations
  Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease.
  Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Stacey Stein, Hyun Soo Kim> ;Cancer Medicine. 2019 Aug 20
• Join now to see all

Lectures

• Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer pat... 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
• Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018